FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/10/007389 [Registered on: 20/10/2016] Trial Registered Retrospectively
Last Modified On: 24/02/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Other 
Public Title of Study   A clinical trial to study the effect of Pankajakasthuri Breath Eazy Mishrit, in patients with cough, cold and breathing difficulties.  
Scientific Title of Study   An open clinical trial for the assessment of efficacy of Pankajakasthuri Breath Eazy Mishrit in patients with Bronchial Asthma. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrGSSreekumar 
Designation  Assistant Professor 
Affiliation  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre 
Address  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram.
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram.
Thiruvananthapuram
KERALA
695572
India 
Phone  09486886362  
Fax  04712293808  
Email  gssreekumarnair@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrGSSreekumar 
Designation  Assistant Professor 
Affiliation  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre 
Address  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram.
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram.
Thiruvananthapuram
KERALA
695572
India 
Phone  09486886362  
Fax  04712293808  
Email  gssreekumarnair@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrSudhakumari 
Designation  Professor 
Affiliation  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre 
Address  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram
Pankajakasthuri Ayurveda Medical College and Post Graduate Centre, Killy, Kattakada, Thiruvananthapuram.
Thiruvananthapuram
KERALA
695572
India 
Phone  08281782290  
Fax  04712293808  
Email  sudha14ayu@gmail.com  
 
Source of Monetary or Material Support  
PANKAJAKASTHURI AYURVEDA MEDICAL COLEGE AND POST GRADUATE CENTER 
 
Primary Sponsor  
Name  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre 
Address  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre,KILLY KATTAKADA, THIRUVANANTHAPURAM 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
ARUNVISAKHS  Chithramsu kandala.p.o. Thiruvananthapuram 695512 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrGSSREEKUMAR  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre  Pankajakasthuri Ayurveda Medical College and Post Graduate Centre,KILLY KATTAKADA, THIRUVANANTHAPURAM
Thiruvananthapuram
KERALA 
09486886362
04712293808
gssreekumarnair@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PANKAJAKASTHURI RESEARCH CENTERIAEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: J454||Moderate persistent asthma, (2) ICD-10 Condition: J454||Moderate persistent asthma, The Patients with Bronchial Asthma visiting PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE OUT PATIENT DEPARATMENTS for consultation.,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NOT APPLICABLE  NOT APPLLICABLE 
Intervention  PANKAJAKASTHURI BREATH EAZY MISHRIT  DOSE : 20ML ROUTE OF ADMINISTRATION : ORAL FREQUENCY : THREE TIMES PER DAY TIME : AFTER FOOD  
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Both sex with equal distributor with or without rhinitis.
3 Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
Asthmatic meet reversibility criteria (15% improvement in FEVI after Beta – 2 agonist inhalation)
5
 
 
ExclusionCriteria 
Details  Mild intermittent, moderate persistent, severe persistent to severe Asthma (As per WHO GINA guidlines of duration more than 6 months)
Dyspnoea due to other disease like Left ventricular failure, COPD (Chronic Bronchitis, Emphysema), Upper respiratory tract obstruction, Bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational Lung disease, tropical pulmonary eosinophilia, Lofflers disease & Allergic Bronchopulmonary Aspergillosis etc.
Diabetes Mellitus and Hypertension.
Severe renal/Hepatic disease
HIV positive cases

Lung Cancer
Pregnant/lactating mother
Patient who need Salbutamol inhaler daily.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
More than 70% of participants had 100% releif Percentage calculation and assessment criteria based on scoring of grading by using the following parameters.
Frequency of swasa vega (Difficulty in respiration)
2Intensity and duration of attack
3Swasa krichrata (Dyspnoea)
4Ghurghurakam (Wheezing)
5Kaphashteevanam(Production of cough) 
SPECIFIC TIME FOR ASSESSING PRIMARY OUTCOME : 6 MONTHS  
 
Secondary Outcome  
Outcome  TimePoints 
More than 70% of participants had 100% releif Percentage calculation and assessment criteria based on scoring of grading by using the following parameters.
Frequency of swasa vega (Difficulty in respiration)
2Intensity and duration of attack
3Swasa krichrata (Dyspnoea)
4Ghurghurakam (Wheezing)
5Kaphashteevanam(Production of cough) 
SPECIFIC TIME FOR ASSESSING SECONDARY OUTCOME : 60 DAYS AND 90 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   07/01/2015 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Will be published once the CTRI registration is obtained. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
This study is a open clinical trial to asses the efficacy of PANKAJAKASTHURI BREATH EAZY MISHRIT in 60 patients with Bronchial Asthma visited the OPD of PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE HOSPITAL from 07.01.15 to 15.08.15. The severity of disease was graded under five scoring scales. The observation and calculations were made on the basis of relevant statistical methods. The primary outcome measure was done at the end of 2nd month and secondary outcome was measured at the end of 4th month, third at the end of 6th month. The observations on the basis of followup was also taken for statistical analysis. The statistical analysis by using paired t test produced the success rate by attaining P<0.001 shows the medicinal value of the product is highly significant in treating the disease- bronchial asthma with high percentage of improvements.
 
Close